Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Form 8.5 (EPT/RI)

12 Apr 2022 14:04

RNS Number : 1561I
Singer Capital Markets Sec Ltd
12 April 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BRAND ARCHITEKTS GROUP PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

BRAND ARCHITEKTS GROUP PLC

(d) Date dealing undertaken:

11 April 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

If YES, specify which:

 

InnovaDerma PLC

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 5P

 

 

Purchase

 

1,732

 

75.551p

 

75p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

12 April 2022

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUURORUAUSAAR
Date   Source Headline
10th Jun 20131:30 pmRNSDirectorate Change
9th Apr 20133:39 pmRNSBoard changes & Trading Update
28th Feb 20137:00 amRNSHalf Yearly Report
26th Feb 20137:00 amRNSResignation of CEO
16th Nov 201210:10 amRNSResult of AGM
15th Nov 20127:00 amRNSTrading Statement
8th Nov 20127:00 amRNSAdviser Change of Name
1st Oct 20122:07 pmRNSPosting of Accounts
19th Sep 20127:00 amRNSFinal Results
14th Jun 20123:52 pmRNSDirector/PDMR Shareholding
24th May 20124:06 pmRNSDirector/PDMR Shareholding
19th Mar 20127:00 amRNSDirector/PDMR Shareholding
1st Mar 20127:00 amRNSDirectorate Change
23rd Feb 20127:00 amRNSHalf Yearly Report
14th Feb 20127:00 amRNSChange of Adviser
11th Jan 20123:54 pmPRNStatement re Swallowfield PLC
10th Jan 201211:33 amRNSBoard changes
5th Jan 20122:19 pmRNSDirector/PDMR Shareholding
12th Dec 201111:08 amRNSDirector/PDMR Shareholding
3rd Nov 20115:18 pmRNSResult of AGM
5th Oct 201110:05 amRNSHolding(s) in Company
4th Oct 20113:20 pmRNSDirector/PDMR Shareholding
4th Oct 20112:20 pmRNSAnnual Report and Accounts
13th Sep 20111:49 pmRNSDirector/PDMR Shareholding
9th Sep 201110:43 amRNSDirector/PDMR Shareholding
7th Sep 20117:00 amRNSFinal Results
25th Jul 20117:00 amRNSBoard changes
8th Jul 201112:17 pmRNSDirectorate Change
14th Jun 20114:45 pmRNSHolding(s) in Company
20th May 20117:00 amRNSTrading Statement
27th Apr 20117:00 amRNSUpdate re Board Structure
8th Apr 201110:10 amRNSResponse to letter from Western Selection
23rd Mar 201111:05 amRNSPosting of Circular
14th Mar 20113:53 pmRNSNotice of General Meeting
23rd Feb 20114:05 pmRNSGeneral Meeting Requisition
19th Jan 20113:20 pmRNSDirectorate Change
8th Dec 20104:35 pmRNSLong Term Incentive Plan - Replacement
8th Dec 20102:56 pmRNSLong Term Incentive Plan
4th Nov 20103:40 pmRNSResult of AGM
22nd Oct 20105:14 pmRNSHolding(s) in Company
22nd Oct 20105:14 pmRNSHolding(s) in Company
22nd Oct 20103:35 pmRNSSwallowfield Scoops International Awards
11th Oct 20105:14 pmRNSDirector/PDMR Shareholding
8th Oct 201011:02 amRNSPosting of Accounts
9th Sep 20107:00 amRNSFinal Results
29th Jul 20107:00 amRNSDirectorate Change
14th Jun 201012:01 pmRNSTrading Update
10th Jun 201011:25 amRNSDirector/PDMR Shareholding
6th Apr 20105:56 pmRNSDirector/PDMR Shareholding
8th Mar 20107:00 amRNSLong Term Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.